BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sagmeister S, Drucker C, Losert A, Grusch M, Daryabeigi A, Parzefall W, Rohr-Udilova N, Bichler C, Smedsrød B, Kandioler D, Grünberger T, Wrba F, Schulte-Hermann R, Grasl-Kraupp B. HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis. J Hepatol 2008;49:955-64. [PMID: 18929421 DOI: 10.1016/j.jhep.2008.06.031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Parzefall W, Freiler C, Lorenz O, Koudelka H, Riegler T, Nejabat M, Kainzbauer E, Grasl-kraupp B, Schulte-hermann R. Superoxide deficiency attenuates promotion of hepatocarcinogenesis by cytotoxicity in NADPH oxidase knockout mice. Arch Toxicol 2015;89:1383-93. [DOI: 10.1007/s00204-014-1298-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Klepeisz P, Sagmeister S, Haudek-Prinz V, Pichlbauer M, Grasl-Kraupp B, Gerner C. Phenobarbital induces alterations in the proteome of hepatocytes and mesenchymal cells of rat livers. PLoS One 2013;8:e76137. [PMID: 24204595 DOI: 10.1371/journal.pone.0076137] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
3 Komposch K, Sibilia M. EGFR Signaling in Liver Diseases. Int J Mol Sci 2015;17:E30. [PMID: 26729094 DOI: 10.3390/ijms17010030] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 10.9] [Reference Citation Analysis]
4 Hou CH, Lin FL, Tong KB, Hou SM, Liu JF. Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway. Biochem Pharmacol 2014;89:453-63. [PMID: 24685520 DOI: 10.1016/j.bcp.2014.03.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
5 Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove R, Xu R, Huang W. miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 2010;52:2148-57. [PMID: 20979124 DOI: 10.1002/hep.23915] [Cited by in Crossref: 140] [Cited by in F6Publishing: 138] [Article Influence: 11.7] [Reference Citation Analysis]
6 Losert A, Lötsch D, Lackner A, Koppensteiner H, Peter-Vörösmarty B, Steiner E, Holzmann K, Grunt T, Schmid K, Marian B, Grasl-Kraupp B, Schulte-Hermann R, Krupitza G, Berger W, Grusch M. The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Lett 2012;319:164-72. [PMID: 22261339 DOI: 10.1016/j.canlet.2012.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
7 Gonzalez-sanchez E, Vaquero J, Fouassier L, Chignard N. E-cadherin, guardian of liver physiology. Clinics and Research in Hepatology and Gastroenterology 2015;39:3-6. [DOI: 10.1016/j.clinre.2014.09.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
8 Kuo PL, Huang MS, Cheng DE, Hung JY, Yang CJ, Chou SH. Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor. J Biol Chem 2012;287:9753-64. [PMID: 22291012 DOI: 10.1074/jbc.M111.321190] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
9 Clapéron A, Mergey M, Aoudjehane L, Ho-Bouldoires TH, Wendum D, Prignon A, Merabtene F, Firrincieli D, Desbois-Mouthon C, Scatton O. Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor. Hepatology. 2013;58:2001-2011. [PMID: 23787814 DOI: 10.1002/hep.26585] [Cited by in Crossref: 56] [Cited by in F6Publishing: 98] [Article Influence: 6.2] [Reference Citation Analysis]
10 Riegler T, Nejabat M, Eichner J, Stiebellehner M, Subosits S, Bilban M, Zell A, Huber WW, Schulte-Hermann R, Grasl-Kraupp B. Proinflammatory mesenchymal effects of the non-genotoxic hepatocarcinogen phenobarbital: a novel mechanism of antiapoptosis and tumor promotion. Carcinogenesis 2015;36:1521-30. [PMID: 26378027 DOI: 10.1093/carcin/bgv135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Rohr-Udilova N, Sieghart W, Eferl R, Stoiber D, Björkhem-Bergman L, Eriksson LC, Stolze K, Hayden H, Keppler B, Sagmeister S, Grasl-Kraupp B, Schulte-Hermann R, Peck-Radosavljevic M. Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. Hepatology 2012;55:1112-21. [PMID: 22105228 DOI: 10.1002/hep.24808] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
12 Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goñi S, Santamaría M, Prieto J, Avila MA. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood) 2009;234:713-25. [PMID: 19429859 DOI: 10.3181/0901-MR-12] [Cited by in Crossref: 88] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
13 Lozano T, Chocarro S, Martin C, Lasarte-Cia A, Del Valle C, Gorraiz M, Sarrión P, Ruiz de Galarreta M, Lujambio A, Hervás-Stubbs S, Sarobe P, Casares N, Lasarte JJ. Genetic Modification of CD8+ T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies. Front Immunol 2019;10:2990. [PMID: 31921216 DOI: 10.3389/fimmu.2019.02990] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Böhm T, Berger H, Nejabat M, Riegler T, Kellner F, Kuttke M, Sagmeister S, Bazanella M, Stolze K, Daryabeigi A, Bintner N, Murkovic M, Wagner K, Schulte-hermann R, Rohr-udilova N, Huber W, Grasl-kraupp B. Food-derived peroxidized fatty acids may trigger hepatic inflammation: A novel hypothesis to explain steatohepatitis. Journal of Hepatology 2013;59:563-70. [DOI: 10.1016/j.jhep.2013.04.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
15 Ødegård J, Sondresen JE, Aasrum M, Tveteraas IH, Guren TK, Christoffersen T, Thoresen GH. Differential effects of epidermal growth factor (EGF) receptor ligands on receptor binding, downstream signalling pathways and DNA synthesis in hepatocytes. Growth Factors 2017;35:239-48. [PMID: 29582692 DOI: 10.1080/08977194.2018.1453506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Suzukawa K, Tomlin J, Pak K, Chavez E, Kurabi A, Baird A, Wasserman SI, Ryan AF. A mouse model of otitis media identifies HB-EGF as a mediator of inflammation-induced mucosal proliferation. PLoS One 2014;9:e102739. [PMID: 25033458 DOI: 10.1371/journal.pone.0102739] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
17 Wright JH, Johnson MM, Shimizu-Albergine M, Bauer RL, Hayes BJ, Surapisitchat J, Hudkins KL, Riehle KJ, Johnson SC, Yeh MM, Bammler TK, Beyer RP, Gilbertson DG, Alpers CE, Fausto N, Campbell JS. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. Int J Cancer. 2014;134:778-788. [PMID: 23929039 DOI: 10.1002/ijc.28421] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
18 Gentilini A, Pastore M, Marra F, Raggi C. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium. Int J Mol Sci. 2018;19. [PMID: 30249019 DOI: 10.3390/ijms19102885] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
19 Gauglhofer C, Sagmeister S, Schrottmaier W, Fischer C, Rodgarkia-Dara C, Mohr T, Stättner S, Bichler C, Kandioler D, Wrba F. Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis. Hepatology. 2011;53:854-864. [PMID: 21319186 DOI: 10.1002/hep.24099] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 7.7] [Reference Citation Analysis]